ArticleCancer medicine2015

Pretreatment biopsy analysis of DAB2IP identifies subpopulation of high-risk prostate cancer patients with worse survival following radiation therapy.

Corbin Jacobs et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.